Open Access
Therapy Intensity Outweighs the Prognostic Importance of the Timing of Chemoradiotherapy in Newly Diagnosed Glioblastoma Patients
JAN LEPPERT, CLAUDIA DITZ, MAXIMILIAN GROHMANN, CHRISTIAN ZIEMANN, CHRISTINA HILLBRICHT, LARYSA LIUBICH, MARIA VITTORIA MATONE, DIRK RADES, JAN GLIEMROTH and ANASTASSIA LÖSER
Anticancer Research October 2024, 44 (10) 4403-4412; DOI: https://doi.org/10.21873/anticanres.17269